Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. FDA Assessing Capability To Amplify Surveillance Of Indian, Chinese OTC Manufacturers - PharmAsia Summit

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency is gathering information to sharpen its risk-assessment approach and determine inspection priorities for nutraceuticals and traditional medicine manufacturers that use a registration loophole to export products to the U.S. under less-stringent oversight.

You may also be interested in...



U.S. FDA China Country Head Chris Hickey On FDA's Mission In China: An Interview With PharmAsia News (Part 2 of 2)

U.S.FDA established offices in China in 2008 to improve oversight of products exported to the U.S., and to establish stronger working relationships with China's State FDA. The mission of the office initially was to implement two export agreements signed with China in December 2007 to enhance regulatory cooperation in the areas of food, drugs, medical devices and animal feed. PharmAsia News' China and Australia bureaus spoke to FDA China Country Director Christopher Hickey about the mission of the China office and progress being made in China. This is part two of a two-part interview; part one appeared in a recent issue of PharmAsia News.

U.S. FDA Commissioner Hamburg Promotes Regulatory Science Collaboration In China Visit

SHANGHAI - China is predicted to become the world's second largest economy by the end of this year, and last week, U.S. FDA Commissioner Margaret Hamburg made her first trip to China to boost communication with China's State FDA and to emphasize that the relationship between the U.S. and China has become more important than ever

FDA Foreign Inspections To Double In 2010, Led By Human Drugs And Food

FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel